As of 2026-02-09, the Fair Value of Arrowhead Pharmaceuticals Inc (ARWR) is -0.06 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 64.52 USD, the upside of Arrowhead Pharmaceuticals Inc is -100.09%.
With the market price of 64.52 USD and our fair value calculation, Arrowhead Pharmaceuticals Inc (ARWR) is not a good investment. Investing in ARWR stocks now will result in a potential loss of 100.09%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 5Y Avg | |
| Net income | -140.80 | -176.10 | -205.30 | -599.49 | -1.63 | -224.66 |
| YoY growth | -66.43% | -25.07% | -16.58% | -192.01% | 99.73% | -40.07% |
| Market Cap (mil) | 8,762.46 |
| P/E | |
| Forward P/E | 163.70x |
| EPS | -0.01 |
| Avg earnings growth rate | -40.07% |
| TTM earnings | -1.63 |